NASDAQ NMS - GLOBAL MARKET · HSCS
+7.44% · +$0.3600 · Vol 174.7K
Market closed · last close 4:00 PM ET · price as of 16:16:57 ET
HeartSciences Inc

HeartSciences Inc

Health Care
$5.20
Card
Relationship Map

Follow $HSCS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $HSCS by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
HSCS
HeartSciences Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

71/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is HSCS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading HSCS catalysts
About HeartSciences Inc
FINANCE SERVICES
Listed since
2022
Employees
14
Country
US

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.79
Day high
$5.21
Day low
$4.68
Previous close
$4.84
52W high
$5.21
-0.19% from high
52W low
$1.67
100% of range
Market cap
$25M
EPS
$-4.8600
Beta
-0.45
Shares out
4.8M
Volume
174.7K
1.21× rel vol
Avg volume
143.8K
VWAP
$5.02
Price history computed in-house
1W
+53.39%
1M
+85.71%
3M
+193.79%
1Y
+49.00%
YTD
+68.28%
SMA 50 $2.79 · above
SMA 200 $2.58 · above
52W position 100%

HSCS overview

Veridion Score
71
Registered · 2026-09-18
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around HSCS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading HSCS Form 4 filings
Public disclosures

Congress activity in HSCS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for HSCS in the cached public ledger.

Federal contracts

HSCS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HSCS in this window.
Lobbying spend

HSCS lobbying filings, year to date.

Registered lobbying filings matched to HeartSciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HSCS in this window.
Loading news for HSCS
Analyst ratings
Sovereign unlock shows live analyst consensus for HSCS.
Options
Sovereign unlock shows live options positioning for HSCS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.